Keating, C., Yonker, L. M., Vermeulen, F., Prais, D., Linnemann, R. W., Trimble, A., Kotsimbos, T., Mermis, J., Braun, A. T., O’Carroll, M., Sutharsan, S., Ramsey, B., Mall, M. A., Taylor-Cousar, J. L., McKone, E. F., Tullis, E., Floreth, T., Michelson, P., Sosnay, P. R., … Horsley, A. (2025). Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(24)00411-9

Shah, J., Saak, T. M., Tervo, J. P., & Overdevest, J. B. (2023). Geospatial air quality complaints and implications for urban respiratory health. The Lancet Respiratory Medicine, 11(11), 963–964. https://doi.org/10.1016/s2213-2600(23)00385-5

Baldwin, M. R. (2023). Making sense of multiorgan MRI imaging for post-acute sequelae of SARS-CoV-2 infection. The Lancet Respiratory Medicine, 11(11), 951–952. https://doi.org/10.1016/s2213-2600(23)00347-8

Mayer-Hamblett, N., Clancy, J. P., Jain, R., Donaldson, S. H., Fajac, I., Goss, C. H., Polineni, D., Ratjen, F., Quon, B. S., Zemanick, E. T., Bell, S. C., Davies, J. C., Jain, M., Konstan, M. W., Kerper, N. R., LaRosa, T., Mall, M. A., McKone, E., Pearson, K., … Downey, D. G. (2023). Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective. The Lancet Respiratory Medicine, 11(10), 932–944. https://doi.org/10.1016/s2213-2600(23)00297-7

Brown, S. M., Barkauskas, C. E., Grund, B., Sharma, S., Phillips, A. N., Leither, L., Peltan, I. D., Lanspa, M., Gilstrap, D. L., Mourad, A., Lane, K., Beitler, J. R., Serra, A. L., Garcia, I., Almasri, E., Fayed, M., Hubel, K., Harris, E. S., Middleton, E. A., … Wenner, C. (2023). Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial. The Lancet Respiratory Medicine, 11(9), 791–803. https://doi.org/10.1016/s2213-2600(23)00147-9

Uluer, A. Z., MacGregor, G., Azevedo, P., Indihar, V., Keating, C., Mall, M. A., McKone, E. F., Ramsey, B. W., Rowe, S. M., Rubenstein, R. C., Taylor-Cousar, J. L., Tullis, E., Yonker, L. M., Chu, C., Lam, A. P., Nair, N., Sosnay, P. R., Tian, S., Van Goor, F., … Wilson, J. (2023). Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11(6), 550–562. https://doi.org/10.1016/s2213-2600(22)00504-5

Tran, A., Fernando, S. M., Rochwerg, B., Barbaro, R. P., Hodgson, C. L., Munshi, L., MacLaren, G., Ramanathan, K., Hough, C. L., Brochard, L. J., Rowan, K. M., Ferguson, N. D., Combes, A., Slutsky, A. S., Fan, E., & Brodie, D. (2023). Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. The Lancet Respiratory Medicine, 11(3), 235–244. https://doi.org/10.1016/s2213-2600(22)00296-x

Martucci, G., Schmidt, M., Agerstrand, C., Tabatabai, A., Tuzzolino, F., Giani, M., Ramanan, R., Grasselli, G., Schellongowski, P., Riera, J., Hssain, A. A., Duburcq, T., Gorjup, V., De Pascale, G., Buabbas, S., Gannon, W. D., Jeon, K., Trethowan, B., Fanelli, V., … Buscher, H. (2023). Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study. The Lancet Respiratory Medicine, 11(3), 245–255. https://doi.org/10.1016/s2213-2600(22)00353-8

Hodgson, C. L., Higgins, A. M., Bailey, M. J., Anderson, S., Bernard, S., Fulcher, B. J., Koe, D., Linke, N. J., Board, J. V., Brodie, D., Buhr, H., Burrell, A. J. C., Cooper, D. J., Fan, E., Fraser, J. F., Gattas, D. J., Hopper, I. K., Huckson, S., Litton, E., … Serpa Neto, A. (2022). Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. The Lancet Respiratory Medicine, 10(11), 1038–1048. https://doi.org/10.1016/s2213-2600(22)00248-x

Stick, S. M., Foti, A., Ware, R. S., Tiddens, H. A. W. M., Clements, B. S., Armstrong, D. S., Selvadurai, H., Tai, A., Cooper, P. J., Byrnes, C. A., Belessis, Y., Wainwright, C., Jaffe, A., Robinson, P., Saiman, L., & Sly, P. D. (2022). The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial. The Lancet Respiratory Medicine, 10(8), 776–784. https://doi.org/10.1016/s2213-2600(22)00165-5

Supady, A., Brodie, D., & Wengenmayer, T. (2022). Extracorporeal haemoadsorption: does the evidence support its routine use in critical care? The Lancet Respiratory Medicine, 10(3), 307–312. https://doi.org/10.1016/s2213-2600(21)00451-3

Bowman, W. S., Newton, C. A., Linderholm, A. L., Neely, M. L., Pugashetti, J. V., Kaul, B., Vo, V., Echt, G. A., Leon, W., Shah, R. J., Huang, Y., Garcia, C. K., Wolters, P. J., & Oldham, J. M. (2022). Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. The Lancet Respiratory Medicine, 10(6), 593–602. https://doi.org/10.1016/s2213-2600(21)00503-8

Beitler, J. R., Thompson, B. T., Baron, R. M., Bastarache, J. A., Denlinger, L. C., Esserman, L., Gong, M. N., LaVange, L. M., Lewis, R. J., Marshall, J. C., Martin, T. R., McAuley, D. F., Meyer, N. J., Moss, M., Reineck, L. A., Rubin, E., Schmidt, E. P., Standiford, T. J., Ware, L. B., … Calfee, C. S. (2022). Advancing precision medicine for acute respiratory distress syndrome. The Lancet Respiratory Medicine, 10(1), 107–120. https://doi.org/10.1016/s2213-2600(21)00157-0